切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2008, Vol. 02 ›› Issue (03) : 231 -234. doi: 10.3877/cma.j.issn.1674-0793.2008.03.017

综述与讲座

CD133在肝细胞癌、胰腺癌研究中的进展
王花1, 李雯1, 汪谦2   
  1. 1.510080 广州,中山大学附属第一医院外科实验室
    2.510080 广州,中山大学附属第一医院肝胆外科
  • 收稿日期:2008-03-11 出版日期:2008-06-01

Development of CD133 in hepatocellular and pancreatic carcinoma

Hua WANG, Wen LI, Qian WANG   

  • Received:2008-03-11 Published:2008-06-01
引用本文:

王花, 李雯, 汪谦. CD133在肝细胞癌、胰腺癌研究中的进展[J/OL]. 中华普通外科学文献(电子版), 2008, 02(03): 231-234.

Hua WANG, Wen LI, Qian WANG. Development of CD133 in hepatocellular and pancreatic carcinoma[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2008, 02(03): 231-234.

肿瘤干细胞是肿瘤发生、发展、转移、复发、对抗放、化疗的根源,近年来研究表明一些实体肿瘤干细胞高度表达CD133表面抗原。针对CD133与肝细胞癌、胰腺癌干细胞的关系的研究,理解CD133+肿瘤干细胞的分子生物学机制对于研究应用有效的、有选择性的诱导凋亡的抗肿瘤药物的靶向性治疗提供了新的发展方向。

1
Lapidot T,Sirard C,Vormoor J,et al.A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.Nature,1994,367(6464):645.
2
Van Dyke T,Jacks T.Cancer modeling in the modern era:progress and challenges.Cell,2002,108(2):135.
3
Hope KJ,Jin L,Dick JE.Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes t hat differ in self renewal capacity.Nat Immunol,2004,5(7):738.
4
Reya T,Morrison SJ,Clarke MF,et al.Stem cells,cancer,and cancer stem cells.Nature,2001,414(6859):105.
5
Richardson GD,Robson CN,Lang SH,et al.CD133,a novel marker for human prostatic epithelial stem cells.J Cell Sci,2004,117(Pt 16):3539-3545.
6
Shmelkov SV,St Clair R,Lyden D,et al.AC133/CD133/Prominin-1.Int J Biochem Cell Biol,2005,37(4):715-719.
7
Singh SK,Clarke ID,Terasaki M,et al.Identification of a cancer stem cell in human brain tumors.Cancer Res,2003,63(18):5821-5828.
8
Kim CF,Jackson EL,Woolfenden AE,et al.Identification of bronchioalveolar stem cells in normal lung and lung cancer.Cell,2005,121(6):823-835.
9
Colins AT,Berry PA,Hyde C,et al.Prospective identification of tumorigenic prostate cancer stem cells.Cancer Res,2005,65(23):10946-10951.
10
Monzani E,Facchetti F,Galmozzi E,et al.Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential.Eur J Cancer,2007,43 (5):935-946.
11
Suetsugu A,Nagaki M,Aoki H,et al.Characterization of CD133+hepatocellular carcinoma cells as cancer stem/progenitor cells.Biochem Biophys Res Commun,2006,351(4):820-824.
12
Olempska M,Eisenach PA,Ammerpohl O,et al.Detection of tumor stem cell markers in pancreatic carcinoma cell lines.Hepatobiliary Pancreat Dis Int,2007,6(1):92-97.
13
Hixson DC,Faris RA,Thompson NL,et al.An antigenic portrait of the liver during carcinogenesis.Pathobiology,1990,58(2):65-77.
14
Lowes KN,Brennan BA,Yeoh GC,et al.Oval cell numbers in human chronic liver diseases are directly related to disease severity.Am J Pathol,1999,154(2):537-541.
15
Yu Y,Flint A,Dvorin EL,et al.AC133-2,a novel isoform of human AC133 stem cell antigen.J Biol Chem,2002,277(23):20711-20716.
16
Uchida N,Buck DW,He D,et al.Direct isolation of human central nervous system stem cells.Proc Natl Acad Sci U S A,2000,97(26):14720-14725.
17
Corbeil D, R?per K, Hellwig A, et al.The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions.J Biol Chem,2000,275(8):5512-5520.
18
Majka M, Ratajczak J, Machalinski B,et al.Expression, regulation and function of AC133, a putative cell surface marker of primitive human haematopoietic cells.Folia Histochem Cytobiol,2000,38(2):53-63.
19
Singh SK,Hawkins C,Clarke ID,et al.Identification of human brain tumour initiating cells.Nature,2004,432(7015):396-401.
20
Yin S,Li J,Hu C,et al.CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity.Int J Cancer,2007,120(7):1444-1450.
21
Zulewski H,AbrahamEJ,Gerlach MJ,et al.Multipotential nestin positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine,exocrine,and hepatic phenotypes.Diabetes,2001,50(3):521-533.
22
Zhou J, Pineyro MA, Wang X ,et al. Exendin-4 differentiation of a human pancreatic duct cell line into endocrine cells: involvement of PDX-1 and HNF3 beta transcription factors.J Cell Physiol,2002,192(3):304-314.
23
Miraglia S, Godfrey W, Yin AH, et al.A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning.Blood,1997,90(12):5013-5021.
24
Yin AH,Miraglia S,Zanjani ED,et al.AC133,a novel marker for human hematopoietic stem and progenitor cells.Blood,1997,90(12):5002-5012.
25
Frank NY, Margaryan A, Huang Y,et al.ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res,2005,65(10):4320-4333.
[1] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[2] 马旦杰, 黄品同, 徐琛, 周芳芳, 潘敏强. 超声造影LI-RADS系统联合甲胎蛋白对有无高危因素背景人群肝细胞癌的诊断价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(03): 288-296.
[3] 李敏, 杨世英, 高晓琴, 周丹, 唐筱, 张立婷. 维生素A与慢性肝病相关性研究进展[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(02): 65-70.
[4] 赵向阳, 刘双池, 张懿刚, 陶滔, 谈燚. 顺铂对肝细胞癌Hep3B细胞程序性死亡配体1表达及药物敏感性的研究[J/OL]. 中华普通外科学文献(电子版), 2024, 18(01): 51-55.
[5] 胡森焱, 徐冬, 方健, 谢冬冬, 王财庆. ICG荧光显影Laennec膜入路腹腔镜解剖性肝切除的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 513-516.
[6] 陈政, 叶庆旺, 赵东波, 石鑫, 吴建强, 余德才. 定位针引导下腹腔镜精准局部肝切除应用探索[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(02): 125-128.
[7] 张瑜, 姜梦妮. 基于DWI信号值构建局部进展期胰腺癌放化疗生存获益预测模型[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 657-664.
[8] 王天福, 王刚. 自身免疫性胰腺炎诊治现状[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 492-497.
[9] 孟煜凡, 李永政, 樊知遥, 展翰翔. 瘤内微生物在胰腺癌发病和演进中的作用机制及研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 577-582.
[10] 莫鹏, 郭杏春, 梁秀娟, 王耀明. 超声引导与CT引导射频消融治疗肝细胞癌患者疗效及预后比较[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(02): 151-154.
[11] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
[12] 楚海强, 杨远游, 任刚. 胰腺癌放射治疗联合其他治疗方法的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(04): 392-396.
[13] 陆知非, 华永飞, 姜哲康, 高过, 江寅, 王高卿. 初始不可切除肝癌转化治疗的影响因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(03): 268-274.
[14] 倪管崟, 缪小赟, 丁家安, 田鹏程, 倪才方. 锥形束计算机断层扫描在肝癌介入诊疗中的应用进展[J/OL]. 中华介入放射学电子杂志, 2024, 12(03): 256-260.
[15] 吴子龙, 吴冰, 袁开盛, 胡瑞翔, 杨华, 王存川. 肥胖与胰腺疾病研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(03): 213-219.
阅读次数
全文


摘要